In this lightning round, we would like to connect experts from the Indian healthcare 3D printing ecosystem with 3DHEALS audiences around the world, highlighting their breakthroughs, and entrepreneurial lives, and opening new conversation channels on partnerships. We have curated a group of highly diverse and representative panelists from dental 3D printing, medical 3D printing, and bioprinting space. While it is impossible to really dive deep into the entrepreneurial culture and ecosystem of the community without actually physically being there, we aim to bring the most influential voices to the virtual event to give everyone a taste of what it is like to invest in, work for, and partner with Indian startups in the space.
Apply to speak or sponsor the future event: email@example.com
Firoza Kothari, Co-Founder & CTO – Anatomiz3D Medtech Pvt. Ltd. – A B.Tech in Biotechnology Engineering and now Forbes 30 under 30 – Asia – Healthcare and Science, 2020, Firoza Kothari started her journey to provide patient-specific medical solutions and one day end the organ donation problem by creating live organs out of patients’ stem cells. With that aspiration, she gave birth to Anatomiz3D, a startup focusing on medical 3D printing. She, along with her team, was the first to execute soft tissue models in India through Paediatric Cardiology, partial amputee prosthetic hand, the first kidney tumor case in India, and the model for tongue cancer was the first in the world. Being a Co-founder and CTO of Anatomiz3D, she, along with her team, has successfully added 2000 plus case studies. Her multi-disciplinary expertise prevails in converting 2D DICOM CT/MRI/Echo Scans to 3D Printed anatomical replicas, medical devices, and allied products, using various combinations of Hardware and Software, across multiple medical specializations. Anatomiz3D has played a vital role in creating the market for 3D Printing in the Medical industry in India since 2015 and is a pioneer for the same, also being the first in India to enable Hospital-Industry partnerships for Point-of-Care Labs.
Dr.Mahesh Kappanayil is a Professor of Pediatric Cardiology at Amrita Institute of Medical Sciences and Research Center, Kochi, Kerala, India. He is also the founder and lead of the 3D Printing, Virtual Reality and Innovation Laboratory at Amrita. As a pediatric cardiologist, he has been involved with various facets of the field including high-end transcatheter interventions, advanced cardiac imaging and clinical research. He helped establish India’s first dedicated cardiac MRI program for congenital heart diseases at Amrita. He has been involved in exploring the application of 3D+ technologies in Healthcare for well over a decade. In 2015-16 he helped establish the region’s first “Point-of-Care” medical 3D printing Lab at Amrita, and in 2020-21 expanded the scope of the lab to Extended Reality applications for medicine. These Labs today are hub of multi-disciplinary innovations in leveraging 3D+ technologies for healthcare applications. He believes that technology is a great equaliser, and cutting-edge technologies of 3D Printing and Extended Reality are set to revoutionalise medicine and healthcare in a big way, even in limited resource environments. Dr.Mahesh has won several national awards and recognitions for his work in this area, and has numerous expert lectures and publications to his credit.
Piyush’s journey into the world of Bioprinting began with his experience in the organ transplantation sector. Post his under graduation from Vellore Institute of Technology, Piyush began his career in the pharmaceutical sector at Biocon Limited and then at Roche Pharmaceuticals, where he worked closely with physicians and transplant coordinators in Kidney and Liver Transplants. The ever-widening gap in organs available for transplant and the need for these organs was very apparent to him. This led him to begin Next Big Innovation Labs® with Alok and Pooja, the other two co-founders of the company. In his role as the CEO and Co-Founder of Next Big Innovation Labs®, Piyush has led various deep technology projects in bioprinting and has also played a pivotal role in raising central and state government funding for the company. Some of the projects he has led are the following: the development of India’s first customized 3D Bioprinter, the development of unique temperature control fixtures for diverse bioprinting components and AI/ML integration into Trivima Bioprinting Systems. Piyush currently holds two technology patents and one process patent in the domain of bioprinting and considers himself to be an eternal student. His goal is to one day bridge the gap in the organ transplantation sector and believes in deep collaborations to achieve this goal.
I have done post my bachelors, taxation, and law along with business management. later joined family business where we are making high purity iron powders and flakes for food, pharma, aerospace and engineering industries exporting to about 30 countries across the world. started 3D Incredible in 2017 with an idea to bring this technology to the masses in India specially with respect to medical applications. so far we have done close to 1400 implants across more than 30 cities in India working and promoting 3d printing with close to 700 surgeons. with respect to engineering, we work with companies across various sectors right from prototyping to small batch production.
Yearla Srinivasa Rao is presently working as a chief operating officer of Medoja Health Private Limited, which is a healthcare company with a focus on 3D printing of patient-specific bespoke customized implants using novel biomaterials, and manufacturing of biomaterials from natural sources for medical 3D printing applications. Bone defects are filled with ceramic granules traditionally in many cases, without considering the shape fidelity to the defect or providing vascular supply. Medoja addressed this by using a ceramic composition which can be 3D printable to address shape fidelity and generate vascular supply to it. Yearla completed his Ph.D. from the University of Hyderabad and has overall 6+ years of post PhD industrial experience in nanomaterials and biomaterials based product development for agriculture, cosmetic, nutraceuticals, and pharmaceutical industries. He managed project activities from BIRAC and DBT during his tenure in the industry along with working in a multidisciplinary environment to manage sales, marketing, production, and business development, teams.